Mirum Pharmaceuticals (MIRM) Cash & Equivalents (2018 - 2026)
Mirum Pharmaceuticals' Cash & Equivalents was $243.19 million in Q3 2026, down 13.8% from $282.02 million a year earlier and down 26.5% from the prior quarter.
Mirum Pharmaceuticals (MIRM) Cash & Equivalents (2018 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Mirum Pharmaceuticals came in at $296.68 million, up 33.1% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of 15.9% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $222.93 million in FY2024 (-22.1%), $286.33 million in FY2023 (+123.7%), $128 million in FY2022 (-2.5%) and $131.34 million in FY2021 (-7.6%).
- The Q3 2026 figure marks the lowest quarterly Cash & Equivalents since Q2 2025.
- Compared with a year earlier, Cash & Equivalents was higher in four of the last eight quarters, with growth averaging 11.2%.
- The best year-over-year quarter for Cash & Equivalents over five years was Q3 2023 (growth of 747.5%); the worst was Q1 2022 (a decline of 49.0%).
- Per Business Quant data, MIRM's Cash & Equivalents in the three quarters before Q3 2026 was $330.73 million (Q2 2026), $324.91 million (Q1 2026) and $296.68 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Mirum Pharmaceuticals | 6.16 Bn | 4.58 Bn | 150.55 Mn | 243.19 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 243.19 Mn |
| Jun 30, 2026 | 330.73 Mn |
| Mar 31, 2026 | 324.91 Mn |
| Dec 31, 2025 | 296.68 Mn |
| Sep 30, 2025 | 282.02 Mn |
| Jun 30, 2025 | 228.12 Mn |
| Mar 31, 2025 | 211.82 Mn |
| Dec 31, 2024 | 222.93 Mn |
| Sep 30, 2024 | 222.97 Mn |
| Jun 30, 2024 | 233.25 Mn |
| Mar 31, 2024 | 302.84 Mn |
| Dec 31, 2023 | 286.33 Mn |
| Sep 30, 2023 | 303.06 Mn |
| Jun 30, 2023 | 297.23 Mn |
| Mar 31, 2023 | 49.42 Mn |
| Dec 31, 2022 | 128.00 Mn |
| Sep 30, 2022 | 35.76 Mn |
| Jun 30, 2022 | 55.27 Mn |
| Mar 31, 2022 | 46.27 Mn |
| Dec 31, 2021 | 131.34 Mn |
Mirum Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MIRM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "MIRM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MIRM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();